SEARCH

SEARCH BY CITATION

References

  • Alonso-Vanegas, M.A., Fawcett, J.P., Causing, C.G., Miller, F.D. & Sadikot, A.F. (1999) Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse. J Comp Neurol 413, 449462.
  • Altar, C.A., Cai, N., Bliven, T., Juhasz, M., Conner, J.M., Acheson, A.L., Lindsay, R.M. & Wiegand, S.J. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856860.
  • Apostol, B.L., Simmons, D.A., Zuccato, C., Illes, K., Pallos, J., Casale, M., Conforti, P., Ramos, C., Roarke, M., Kathuria, S., Cattaneo, E., Marsh, J.L. & Thompson, L.M. (2008) CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice. Mol Cell Neurosci 39, 820.
  • Bailoo, J.D., Bohlen, M.O. & Wahlsten, D. (2010) The precision of video and photocell tracking systems and the elimination of tracking errors with infrared backlighting. J Neurosci Methods 188, 4552.
  • Baquet, Z.C., Bickford, P.C. & Jones, K.R. (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25, 62516259.
  • Baquet, Z.C., Gorski, J.A. & Jones, K.R. (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24, 42504258.
  • Beaudry, G., Langlois, M.C., Weppe, I., Rouillard, C. & Levesque, D. (2000) Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem 75, 16941702.
  • Berendse, H.W. & Groenewegen, H.J. (1990) Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 299, 187228.
  • Bjorklund, A. & Dunnett, S.B. (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30, 194202.
  • Bolivar, V.J., Manley, K. & Messer, A. (2003) Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav Neurosci 117, 12331242.
  • Borrell-Pages, M., Zala, D., Humbert, S. & Saudou, F. (2006) Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63, 26422660.
  • Canals, J.M., Pineda, J.R., Torres-Peraza, J.F., Bosch, M., Martin-Ibanez, R., Munoz, M.T., Mengod, G., Ernfors, P. & Alberch, J. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24, 77277739.
  • Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. & Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19, 32483257.
  • Cattaneo, E., Zuccato, C. & Tartari, M. (2005) Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 6, 919930.
  • Conner, J.M., Lauterborn, J.C., Yan, Q., Gall, C.M. & Varon, S. (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17, 22952313.
  • Cowin, R.M., Bui, N., Graham, D., Green, J.R., Yuva-Paylor, L.A., Weiss, A. & Paylor, R. (2012) Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington's disease pathogenesis. Mamm Genome 23, 367377.
  • Coyle, J.T. & Schwarcz, R. (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263, 244246.
  • Cummings, D.M., Alaghband, Y., Hickey, M.A., Joshi, P.R., Hong, S.C., Zhu, C., Ando, T.K., Andre, V.M., Cepeda, C., Watson, J.B. & Levine, M.S. (2012) A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease. J Neurophysiol 107, 677691.
  • DeMarch, Z., Giampa, C., Patassini, S., Bernardi, G. & Fusco, F.R. (2008) Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 30, 375387.
  • Dunham, N.W. & Miya, T.S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 46, 208209.
  • Dunnett, S.B., Carter, R.J., Watts, C., Torres, E.M., Mahal, A., Mangiarini, L., Bates, G. & Morton, A.J. (1998) Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 154, 3140.
  • Duyao, M., Ambrose, C., Myers, R. et al. (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4, 387392.
  • Fawcett, J.P., Alonso-Vanegas, M.A., Morris, S.J., Miller, F.D., Sadikot, A.F. & Murphy, R.A. (2000) Evidence that brain-derived neurotrophic factor from presynaptic nerve terminals regulates the phenotype of calbindin-containing neurons in the lateral septum. J Neurosci 20, 274282.
  • Ferrante, R.J., Kowall, N.W., Beal, M.F., Richardson, E.P. Jr., Bird, E.D. & Martin, J.B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561563.
  • Ferrer, I., Goutan, E., Marin, C., Rey, M.J. & Ribalta, T. (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866, 257261.
  • File, S.E., Mahal, A., Mangiarini, L. & Bates, G.P. (1998) Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 805, 234240.
  • Franklin, K.B.J. & Paxinos, G. (2008). The mouse brain in stereotaxic coordinates. Elsevier/Academic Press, Amsterdam; Boston.
  • Fryer, R.H., Kaplan, D.R., Feinstein, S.C., Radeke, M.J., Grayson, D.R. & Kromer, L.F. (1996) Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol 374, 2140.
  • Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S. & Saudou, F. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127138.
  • Gharami, K., Xie, Y., An, J.J., Tonegawa, S. & Xu, B. (2008) Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J Neurochem 105, 369379.
  • Gil, J.M. & Rego, A.C. (2009) The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Brain Res Rev 59, 410431.
  • Giralt, A., Carreton, O., Lao-Peregrin, C., Martin, E.D. & Alberch, J. (2011) Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6, 71.
  • Gundersen, H.J., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sorensen, F.B. & Vesterby, A. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857881.
  • Hickey, M.A., Gallant, K., Gross, G.G., Levine, M.S. & Chesselet, M.F. (2005) Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 20, 111.
  • Hickey, M.A., Kosmalska, A., Enayati, J., Cohen, R., Zeitlin, S., Levine, M.S. & Chesselet, M.F. (2008) Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 157, 280295.
  • Hillarp, N.A., Fuxe, K. & Dahlstrom, A. (1966) Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev 18, 727741.
  • Hockly, E., Cordery, P.M., Woodman, B., Mahal, A., van Dellen, A., Blakemore, C., Lewis, C.M., Hannan, A.J. & Bates, G.P. (2002) Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol 51, 235242.
  • Hofer, M., Pagliusi, S.R., Hohn, A., Leibrock, J. & Barde, Y.A. (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9, 24592464.
  • Huntington's disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971983.
  • Hyman, C., Hofer, M., Barde, Y.A., Juhasz, M., Yancopoulos, G.D., Squinto, S.P. & Lindsay, R.M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230232.
  • Jones, B.J. & Roberts, D.J. (1968) The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. J Pharm Pharmacol 20, 302304.
  • Kim, J., Bordiuk, O.L. & Ferrante, R.J. (2011) Experimental models of HD and reflection on therapeutic strategies. Int Rev Neurobiol 98, 419481.
  • Klapstein, G.J., Fisher, R.S., Zanjani, H., Cepeda, C., Jokel, E.S., Chesselet, M.F. & Levine, M.S. (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol 86, 26672677.
  • Laforet, G.A., Sapp, E., Chase, K., McIntyre, C., Boyce, F.M., Campbell, M., Cadigan, B.A., Warzecki, L., Tagle, D.A., Reddy, P.H., Cepeda, C., Calvert, C.R., Jokel, E.S., Klapstein, G.J., Ariano, M.A., Levine, M.S., DiFiglia, M. & Aronin, N. (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci 21, 91129123.
  • Lione, L.A., Carter, R.J., Hunt, M.J., Bates, G.P., Morton, A.J. & Dunnett, S.B. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 19, 1042810437.
  • Luesse, H.G., Schiefer, J., Spruenken, A., Puls, C., Block, F. & Kosinski, C.M. (2001) Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus. Behav Brain Res 126, 185195.
  • Luk, K.C., Kennedy, T.E. & Sadikot, A.F. (2003) Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism. J Neurosci 23, 22392250.
  • Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D., Young, A.B., Tapscott, S.J. & Olson, J.M. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11, 19111926.
  • Luthi-Carter, R., Strand, A., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G., Ross, C.A., Borchelt, D.R., Tapscott, S.J., Young, A.B., Cha, J.H. & Olson, J.M. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 9, 12591271.
  • Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. & Bates, G.P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493506.
  • Menalled, L., El-Khodor, B.F., Patry, M., Suarez-Farinas, M., Orenstein, S.J., Zahasky, B., Leahy, C., Wheeler, V., Yang, X.W., MacDonald, M., Morton, A.J., Bates, G., Leeds, J., Park, L., Howland, D., Signer, E., Tobin, A. & Brunner, D. (2009) Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis 35, 319336.
  • Menalled, L., Zanjani, H., MacKenzie, L., Koppel, A., Carpenter, E., Zeitlin, S. & Chesselet, M.F. (2000) Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp Neurol 162, 328342.
  • Menalled, L.B., Patry, M., Ragland, N., Lowden, P.A., Goodman, J., Minnich, J., Zahasky, B., Park, L., Leeds, J., Howland, D., Signer, E., Tobin, A.J. & Brunner, D. (2010) Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. PLoS One 5, e9793.
  • Monville, C., Torres, E.M. & Dunnett, S.B. (2006) Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods 158, 219223.
  • Nance, M.A. & Myers, R.H. (2001) Juvenile onset Huntington's disease--clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7, 153157.
  • O'Keefe, J., Nadel, L. & Willner, J. (1979) Tuning out irrelevancy? Comments on Solomon's temporal mapping view of the hippocampus. Psychol Bull 86, 12801289.
  • Parent, A. & Hazrati, L.N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20, 91127.
  • Parent, M. & Parent, A. (2010) Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship. Can J Neurol Sci 37, 313319.
  • Paulsen, J.S. (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11, 474483.
  • Peng, Q., Masuda, N., Jiang, M., Li, Q., Zhao, M., Ross, C.A. & Duan, W. (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 210, 154163.
  • Pineda, J.R., Canals, J.M., Bosch, M., Adell, A., Mengod, G., Artigas, F., Ernfors, P. & Alberch, J. (2005) Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. J Neurochem 93, 10571068.
  • Radka, S.F., Holst, P.A., Fritsche, M. & Altar, C.A. (1996) Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709, 122301.
  • Raymond, L.A., Andre, V.M., Cepeda, C., Gladding, C.M., Milnerwood, A.J. & Levine, M.S. (2011) Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198, 252273.
  • Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B. & Young, A.B. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85, 57335737.
  • Reiner, A., Dragatsis, I. & Dietrich, P. (2011) Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol 98, 325372.
  • Richfield, E.K., Maguire-Zeiss, K.A., Vonkeman, H.E. & Voorn, P. (1995) Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38, 852861.
  • Robitaille, Y., Lopes-Cendes, I., Becher, M., Rouleau, G. & Clark, A.W. (1997) The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol 7, 901926.
  • Rosas, H.D., Koroshetz, W.J., Chen, Y.I., Skeuse, C., Vangel, M., Cudkowicz, M.E., Caplan, K., Marek, K., Seidman, L.J., Makris, N., Jenkins, B.G. & Goldstein, J.M. (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60, 16151620.
  • Ruskin, D.N., Ross, J.L., Kawamura, M. Jr., Ruiz, T.L., Geiger, J.D. & Masino, S.A. (2011) A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. Physiol Behav 103, 501507.
  • Rustay, N.R., Wahlsten, D. & Crabbe, J.C. (2003) Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 141, 237249.
  • Rymar, V.V., Sasseville, R., Luk, K.C. & Sadikot, A.F. (2004) Neurogenesis and stereological morphometry of calretinin-immunoreactive GABAergic interneurons of the neostriatum. J Comp Neurol 469, 325339.
  • Sadikot, A.F., Leung, K., Mittal, S., Rymar, V.V., Alonso-Vanegas, M. & Luk, K.C. (2005). Anterograde trophic mechanisms participate in pattern formation in the striatum: A role for BDNF in glutamatergic afferents. Springer, Singapore.
  • Sadikot, A.F., Parent, A. & Francois, C. (1992a) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 315, 137159.
  • Sadikot, A.F., Parent, A., Smith, Y. & Bolam, J.P. (1992b) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity. J Comp Neurol 320, 228242.
  • Sadikot, A.F. & Sasseville, R. (1997) Neurogenesis in the mammalian neostriatum and nucleus accumbens: parvalbumin-immunoreactive GABAergic interneurons. J Comp Neurol 389, 193211.
  • Sadikot, A.F. & Rymar, V.V. (2009) The primate centromedian-parafascicular complex: anatomical organization with a note on neuromodulation. Brain Res Bull 78, 122130.
  • Sapp, E., Penney, J., Young, A., Aronin, N., Vonsattel, J.P. & DiFiglia, M. (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58, 165173.
  • Saudou, F. & Humbert, S. (2008) The biology of Huntington's disease. Handb Clin Neurol 89, 619629.
  • Schmitz, C., Schuster, D., Niessen, P. & Korr, H. (1999) No difference between estimated mean nuclear volumes of various types of neurons in the mouse brain obtained on either isotropic uniform random sections or conventional frontal or sagittal sections. J Neurosci Methods 88, 7182.
  • Seo, H., Sonntag, K.C. & Isacson, O. (2004) Generalized brain and skin proteasome inhibition in Huntington's disease. Ann Neurol 56, 319328.
  • Seroogy, K.B., Lundgren, K.H., Tran, T.M., Guthrie, K.M., Isackson, P.J. & Gall, C.M. (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342, 321334.
  • Simmons, D.A., Mehta, R.A., Lauterborn, J.C., Gall, C.M. & Lynch, G. (2011) Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice. Neurobiol Dis 41, 436444.
  • Smith, Y., Bennett, B.D., Bolam, J.P., Parent, A. & Sadikot, A.F. (1994) Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol 344, 119.
  • Smith, Y., Raju, D., Nanda, B., Pare, J.F., Galvan, A. & Wichmann, T. (2009) The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull 78, 6068.
  • Sourkes, T.L. & Poirier, L. (1965) Influence of the substantia nigra on the concentration of 5-hydroxytryptamine and dopamine of the striatum. Nature 207, 202203.
  • Spires, T.L., Grote, H.E., Varshney, N.K., Cordery, P.M., van Dellen, A., Blakemore, C. & Hannan, A.J. (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 24, 22702276.
  • Stack, E.C., Dedeoglu, A., Smith, K.M., Cormier, K., Kubilus, J.K., Bogdanov, M., Matson, W.R., Yang, L., Jenkins, B.G., Luthi-Carter, R., Kowall, N.W., Hersch, S.M., Beal, M.F. & Ferrante, R.J. (2007) Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. J Neurosci 27, 1290812915.
  • Stack, E.C., Kubilus, J.K., Smith, K., Cormier, K., Del Signore, S.J., Guelin, E., Ryu, H., Hersch, S.M. & Ferrante, R.J. (2005) Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J Comp Neurol 490, 354370.
  • Stout, J.C., Paulsen, J.S., Queller, S., Solomon, A.C., Whitlock, K.B., Campbell, J.C., Carlozzi, N., Duff, K., Beglinger, L.J., Langbehn, D.R., Johnson, S.A., Biglan, K.M. & Aylward, E.H. (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25, 114.
  • Sun, Z., Del Mar, N., Meade, C., Goldowitz, D. & Reiner, A. (2002) Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease. Neurobiol Dis 11, 369385.
  • Tepper, J.M., Abercrombie, E.D. & Bolam, J.P. (2007) Basal ganglia macrocircuits. Prog Brain Res 160, 37.
  • Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G.P. & Davies, S.W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A 97, 80938097.
  • von Bartheld, C.S., Byers, M.R., Williams, R. & Bothwell, M. (1996) Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system. Nature 379, 830833.
  • Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. & Richardson, E.P. Jr. (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44, 559577.
  • Vonsattel, J.P., Keller, C. & Cortes Ramirez, E.P. (2011) Huntington's disease – neuropathology. In Weiner, W.J. & Tolosa, E. (eds), Handbook of Clinical Neurology: Hyperkinetic Movement Disorders. Vol. 100. Elsevier, Amsterdam, pp. 83100.
  • Wood, N.I., Glynn, D. & Morton, A.J. (2011) "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease. Neurobiol Dis 42, 427437.
  • Wu, L.L., Fan, Y., Li, S., Li, X.J. & Zhou, X.F. (2010) Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285, 56145623.
  • Xie, Y., Hayden, M.R. & Xu, B. (2010) BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J Neurosci 30, 1470814718.
  • Zuccato, C. & Cattaneo, E. (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81, 294330.
  • Zuccato, C. & Cattaneo, E. (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5, 311322.
  • Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B.R., Goffredo, D., Conti, L., MacDonald, M.E., Friedlander, R.M., Silani, V., Hayden, M.R., Timmusk, T., Sipione, S. & Cattaneo, E. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493498.
  • Zuccato, C., Liber, D., Ramos, C., Tarditi, A., Rigamonti, D., Tartari, M., Valenza, M. & Cattaneo, E. (2005) Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res 52, 133139.
  • Zuccato, C., Marullo, M., Conforti, P., MacDonald, M.E., Tartari, M. & Cattaneo, E. (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol 18, 225238.
  • Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T., Rigamonti, D. & Cattaneo, E. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35, 7683.
  • Zuccato, C., Valenza, M. & Cattaneo, E. (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90, 905981.